A Randomized Phase III Study of Intensive Consolidation With High Dose Cytosine Arabinoside in Acute Myelogenous Leukemia (AML-8B)
Clinical trial NCT01324063 · COMPLETED
Trial details
- NCT number
- NCT01324063
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1986-11-01
- Primary completion
- 1994-06-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.